Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacokinetics (PK) of Piperacillin/Tazobactam in Adults Undergoing Extracorporeal Membrane Oxygenation (ECMO)

NCT03467854 is registered in ClinicalTrials.gov with Columbia University as lead sponsor.

NCT NCT03467854
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03467854 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacokinetics (PK) of Piperacillin/Tazobactam in Adults Undergoing Extracorporeal Membrane Oxygenation (ECMO)
Lead sponsor
Columbia University
Phase
Observational
Overall status
Terminated
Start date
January 1, 2019
Completion date
September 24, 2024
Enrollment
2 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute respiratory failure with hypoxia